Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-03-15
1997-10-07
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 424 851, A61K 3518, A61K 3818, C07K 14495, C07K 100
Patent
active
056748434
ABSTRACT:
TGF.beta. is used to increase the numbers of stem cells in a subject's peripheral blood. Then the subject's blood is drawn and the stem cells removed. After myelosuppressive therapy is administered to the subject, the stem cells are administered to the subject. An alternate method provides for TGF.beta. administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed; after a recipient subject receives myelosuppressive therapy, the stem cells are administered to the recipient subject.
REFERENCES:
patent: 4774322 (1988-09-01), Seyedin et al.
patent: 5278145 (1994-01-01), Kellar et al.
patent: 5426098 (1995-06-01), Carlino
Chiefetz et al., "The Transforming growth factor-.beta.system, a complex pattern of cross-reactive ligands and receptors" Cell (1987) 48:409-415.
Ikeda et al., "Human transforming growth factor type .beta.2: Production by a prostatic adenocarcinoma cell line, purification, and initial characterization" Biochemistry (1987) 26:2406-2410.
Seyedin et al., "Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-.beta." J. Biol. Chem. (1987) 262(5):1946-1949.
Dernyck et al., "A new type of transforming growth factor-.beta., TGF-.beta.3" EMBO J. (1988) 7(12):3737-3743.
Madisen et al., "Transforming growth factor-.beta.2: cDNA cloning and sequence analysis" DNA (1988) 7(1):1-8.
Ignotz, "Transforming growth factor-.beta. stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix" J. Biol. Chem. (1986) 261(9):4337-4345.
Goey et al., "Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-.beta.1" J. Immunol. (1989) 143(3):877-880.
Carlino et al., "TGF-.beta.2 decreases chemotherapy-induced mortality in mice" J. Cell. Biochem. (1993) 178:61 (abstract No. E 105).
Carlino et al., "Transforming growth factor .beta.1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice" Exp. Hematol. (1992) 20:943-950.
Hestdal et al., "Increased granulopoiesis after sequential administration of transforming growth factor-.beta.1 and granulocyte-macrophage colony-stimulating factor" Exp. Hematol. (1993) 21:799-805.
Massague, "The TGF-.beta. family of growth and differentiation factors" Cell (1987) 49:437-438.
Roberts et al., "Transforming growth factor .beta." Adv. Cancer Res. (1988) 51:107-145.
Ellingsworth et al., "Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor .beta." J. Biol. Chem. (1986) 261(26):12362-12367.
Kessinger et al., "The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies" Blood (1991) 77(2):211-213.
Kessinger et al., "Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy" Blood (1988) 71(3):723-727.
Kessinger et al., "High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma" Blood (1989) 74(4):1260-1265.
Morse et al., "Peripheral blood stem cell transfusion for marrow replacement" Annals Clin. Lab. Sci. (1992) 22(4):221-225.
Takaue et al., "Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer" Blood (1989) 74(4):1245-1251.
Celtrix Pharmaceuticals Inc.
Touzeau P. Lynn
Tsang Cecilia J.
LandOfFree
Increase in hematopoietic progenitor cells in peripheral blood b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Increase in hematopoietic progenitor cells in peripheral blood b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Increase in hematopoietic progenitor cells in peripheral blood b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357362